Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-09

Clinical Trial Update: Dynepo Long-Term Safety Study [Phase 4]

View source ↗

Summary

Phase 4 long-term safety study of Dynepo has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dynepo

Snippet

Sponsor: Shire | Conditions: Anemia, Kidney Failure, Chronic | Phase 4 | Status: TERMINATED | Results posted: 2009-11-09